GlassScriptPhysician profile
Margaret M Egan
NPI 1881602225
$1,033.26
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $240 · 2021: $365 · 2023: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $105.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $164.36 | 2021 | |
| Janssen Pharmaceuticals, INC | $137.19 | 2019 | |
| Novo Nordisk INC | $136.19 | 2020-2021 | |
| Abbvie INC. | $121.85 | 2021 | |
| Pfizer INC. | $107.74 | 2019-2021 | |
| Glaxosmithkline, LLC. | $105.78 | 2023 | Arexvy |
| Kvk-Tech, INC. | $56.38 | 2019 | |
| Amarin Pharma, INC. | $45.66 | 2020-2021 | |
| Allergan, INC. | $39.78 | 2020 | |
| Eisai INC. | $28.79 | 2020 | |
| Radius Health, INC. | $18.17 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.83 | 2019 | |
| Abbott Laboratories | $16.78 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.32 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.12 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Egan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.